Event chart ASCENDIS PHARMA A/S |
|
|
Upcoming events on ASCENDIS PHARMA A/S |
|
06/01/23 | | Q1 2023 Earnings Release (Projected) |
08/30/23 | | Interim 2023 Earnings Release (Projected) |
11/29/23 | | Q3 2023 Earnings Release (Projected) |
04/03/24 | | FY 2023 Earnings Release (Projected) |
|
Past events on ASCENDIS PHARMA A/S |
|
03/15/23 | 12:00pm | | Oppenheimer Healthcare Conference |
02/28/23 | | Wells Fargo West Coast Biotech Tour |
02/16/23 | 05:30pm | | FY 2022 Earnings Call |
02/16/23 | 05:01pm | | FY 2022 Earnings Release |
01/09/23 | 01:00pm | | JP Morgan Healthcare Conference |
12/01/22 | 02:00pm | | Evercore ISI HealthCONx Conference - Fireside Chat |
11/14/22 | 09:00am | | TransCon CNP ACcomplisH Trial Topline Results |
11/08/22 | | Society for Immunotherapy of Cancer Meeting |
11/02/22 | 04:30pm | | Q3 2022 Earnings Call |
11/02/22 | 04:01pm | | Q3 2022 Earnings Release |
|
Past dividends on ASCENDIS PHARMA A/S |
|
- No events available -
|
|
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Sales M € |
Released Forecast Spread | 10,6 0,22 4 681% | 13,4 12,4 8,0% | 6,95 8,81 -21% | 7,78 6,54 19% | 51,2 45,5 13% | 150 |
Operating income (EBITDA) M € |
Released Forecast Spread | -154 -164 6,0% | -220 -214 -2,7% | -321 -301 -6,6% | -436 -436 -0,17% | -544 -535 -1,6% | -497 |
Operating profit (EBIT) M € |
Released Forecast Spread | -155 -161 4,1% | -227 -219 -3,4% | -331 -308 -7,4% | -452 -453 0,36% | -562 -556 -1,1% | -548 |
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -130 -141 7,3% | -218 -196 -11% | -419 -353 -19% | -384 -408 5,9% | -578 -543 -6,4% | -569 |
Net income M € |
Released Forecast Spread | -130 -140 6,8% | -218 -196 -11% | -419 -354 -18% | -384 -406 5,5% | -583 -530 -10% | -573 |
EPS € |
Released Forecast Spread | -3,17 -3,40 6,8% | -4,69 -4,18 -12% | -8,28 -6,98 -19% | -7,00 -7,49 6,5% | -10,4 -9,56 -8,8% | -10,1 | Announcement Date | 04/03/2019 | 04/01/2020 | 03/10/2021 | 03/02/2022 | 02/16/2023 | - |
|
|
Fiscal Period : December | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
Sales M € |
Released Forecast Spread | 0,54 1,67 -68% | 0,75 1,64 -55% | 1,02 0,75 36% | 1,11 1,14 -2,4% | 4,90 2,66 84% | 6,83 4,47 53% | 6,16 5,81 6,0% | 15,3 8,81 74% | 22,9 18,8 21% | 21,0 | 25,7 | 44,0 | 66,9 | 68,1 |
Operating income (EBITDA) M € |
Released Forecast Spread | -92,7 -89,4 -3,7% | -121 -104 -16% | -114 -118 3,4% | -93,1 -120 22% | -108 -128 15% | -124 -116 -6,6% | -138 -110 -25% | -140 -122 -15% |
| -140 | -119 | -139 | -106 |
|
Operating profit (EBIT) M € |
Released Forecast Spread | -95,6 -87,2 -9,7% | -125 -95,6 -30% | -118 -118 0,01% | -96,9 -121 20% | -113 -120 6,2% | -128 -117 -9,1% | -142 -128 -11% | -145 -143 -1,0% | -147 -144 -2,3% | -150 | -151 | -145 | -129 | -137 |
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -139 -86,1 -61% | -63,0 -94,2 33% | -134 -123 -9,5% | -80,3 -125 36% | -106 -125 15% | -125 -118 -6,4% | -81,4 -129 37% | -169 -140 -21% | -202 -149 -36% | -154 | -154 | -151 | -131 | -133 |
Net income M € |
Released Forecast Spread | -139 -85,7 -62% | -62,8 -95,1 34% | -134 -119 -13% | -80,3 -124 35% | -106 -124 15% | -125 -115 -8,7% | -81,3 -120 32% | -169 -142 -19% | -207 -138 -50% | -153 | -153 | -149 | -134 | -133 |
EPS € |
Released Forecast Spread | -2,64 -1,63 -62% | -1,17 -1,79 35% | -2,50 -2,22 -13% | -1,47 -2,27 35% | -1,87 -2,31 19% | -2,21 -1,99 -11% | -1,46 -2,11 31% | -3,03 -2,53 -20% | -3,70 -2,48 -49% | -2,71 | -2,70 | -2,58 | -2,29 | -2,28 | Announcement Date | 03/10/2021 | 05/27/2021 | 08/25/2021 | 11/10/2021 | 03/02/2022 | 05/11/2022 | 08/10/2022 | 11/02/2022 | 02/16/2023 | - | - | - | - | - | |
|
|
Upcoming sector events for ASCENDIS PHARMA A/S |
|
|
|
Past sector events for ASCENDIS PHARMA A/S |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|